Ambulatory care for multidrug-resistant tuberculosis: lessons learned in Addis Ababa, Ethiopia

D. Fiseha, H. Kumssa, M. Tefera, A. Tesfaye, E. Klinkenberg, G. Yimer

Research output: Contribution to JournalArticleAcademicpeer-review


Ethiopia is one of the high multidrug-resistant tuberculosis (MDR-TB) burden countries. Efforts by the National TB Programme to control MDR-TB include expanding ambulatory care. To investigate the opportunities and challenges faced by treatment follow-up health centres (TFCs) when managing MDR-TB patients, with greater focus on recording, TB infection control (IC) and supervision practices. A facility-based cross-sectional study was conducted by reviewing the records of all MDR-TB cases in all 25 TFCs in Addis Ababa, Ethiopia. The TB focal point, pharmacy and laboratory heads were also interviewed. A total of 221 MDR-TB patients were registered; 157 (71%) patients had been referred from one of the two treatment initiating centres. While some TFCs oversaw up to 41 patients, others had just one patient. The majority of the TFCs (n = 21, 84%) followed standardised TB IC procedures. Poor documentation of patient information was observed at all sites; for example, human immunodeficiency virus and current treatment status was not indicated for respectively 86 (38%) and 41 (18%) patients. The study revealed that infection prevention practices were largely adhered to. Documentation of patient-related information was a major challenge, and regular supervision of the TFCs should be emphasised. Record keeping is critical. Abstract available from the publisher. Abstract available from the publisher
Original languageEnglish
Pages (from-to)S37-S41
JournalPublic Health Action
Issue numberSuppl 3
Publication statusPublished - 2014

Cite this